BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4339423)

  • 1. Low renin hypertension and the adrenal cortex.
    Spark RF
    N Engl J Med; 1972 Aug; 287(7):343-9. PubMed ID: 4339423
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of ACTH and salt on blood pressure and steroid secretion in rats.
    De Nicola AF; De la Riva IJ; Basso N; Dahl V; Kaplan S
    Acta Physiol Lat Am; 1972; 22(4):231-40. PubMed ID: 4349174
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathophysiology of angiotensin-salt hypertension.
    Muirhead EE; Leach BE; Davis JO; Armstrong FB; Pitcock JA; Brosius WL
    J Lab Clin Med; 1975 May; 85(5):734-45. PubMed ID: 1123557
    [No Abstract]   [Full Text] [Related]  

  • 5. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
    Espiner EA; Mansfield H; Miles K
    N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension and hyperaldosteronism with low plasma renin concentration: analysis of a series of eighty-two patients.
    Brown JJ; Chinn RH; Düsterdieck GO; Fraser R; Gleadle RH; Lever AF; Robertson JI; Tree M
    Proc R Soc Med; 1969 Dec; 62(12):1258-60. PubMed ID: 5363111
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of glucocorticoid-responsive hyperaldosteronism.
    Miura K; Yoshinaga K; Goto K; Katsushima I; Maebashi M; Demura H; Iino M; Demura R; Torikai T
    J Clin Endocrinol Metab; 1968 Dec; 28(12):1807-15. PubMed ID: 4301765
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on incidence of primary aldosteronism: current estimations based on objective data.
    Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):152-4. PubMed ID: 4884278
    [No Abstract]   [Full Text] [Related]  

  • 9. Spironolactone, a reassessment.
    Med Lett Drugs Ther; 1975 Oct; 17(21):86-7. PubMed ID: 1186603
    [No Abstract]   [Full Text] [Related]  

  • 10. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal regulation of aldosterone in hypertension.
    Luetscher JA; Ganguly A; Melada GA; Dowdy AJ
    Adv Intern Med; 1975; 20():183-96. PubMed ID: 163569
    [No Abstract]   [Full Text] [Related]  

  • 12. Dexamethasone-suppressible hyperaldosteronism.
    New MI; Siegal EJ; Peterson RE
    J Clin Endocrinol Metab; 1973 Jul; 37(1):93-100. PubMed ID: 4351777
    [No Abstract]   [Full Text] [Related]  

  • 13. Deoxycorticosterone secretion in the bullfrog: effects of ACTH, hypophysectomy, and renin.
    Taylor AA; Davis JO; Braverman B
    Am J Physiol; 1972 Oct; 223(4):858-63. PubMed ID: 4342377
    [No Abstract]   [Full Text] [Related]  

  • 14. Spironolactone and hydrochlorothiazide in essential hypertension. Blood pressure response and plasma renin activity.
    Adlin EV; Marks AD; Channick BJ
    Arch Intern Med; 1972 Dec; 130(6):855-8. PubMed ID: 5082465
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental bases of the pathophysiology of the renin-angiotensin system].
    Gross F
    Verh Dtsch Ges Inn Med; 1968; 74():27-41. PubMed ID: 4306314
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
    Vetter H; Vetter W
    Klin Wochenschr; 1975 Apr; 53(8):391-3. PubMed ID: 211313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spironolactone-induced changes of the renin-angiotensin-aldosterone system and blood pressure lowering in essential hypertension].
    Furrer J; Vetter W; Nussberger J; Beckerhoff R; Siegenthaler W
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():235-6. PubMed ID: 349929
    [No Abstract]   [Full Text] [Related]  

  • 18. Mineralocorticoid hormones.
    Stockigt JR
    Adv Steroid Biochem Pharmacol; 1976; 5():161-238, 334-5. PubMed ID: 180781
    [No Abstract]   [Full Text] [Related]  

  • 19. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.
    Kremer D; Beevers DG; Brown JJ; Davies DL; Ferriss JB; Fraser R; Lever AF; Robertson JI
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():213s-8. PubMed ID: 4361398
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of the adrenal cortex in the pathogenesis of hypertension].
    Vogt JH
    Tidsskr Nor Laegeforen; 1970 Nov; 90(21):2000-7. PubMed ID: 4320157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.